Seattle Genetics Inc. (SGEN) posted a fourth quarter loss of $12.1 million or $0.12 per share, compared to a loss of $30.6 million or $0.38 per share in the prior year quarter.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.23 per share. Analysts' estimates typically exclude special items.
Revenues in the fourth quarter were $21.8 million, compared to $10.1 million in the previous year period. Nine Wall Street analysts expected revenues of $11.71 million.
Looking forward, for the fiscal year 2010, Seattle Genetics expects revenues to be in the range of $95 million to $105 million. Wall Street analysts expect revenues of $47.32 million.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.